References
- Ariño, H., Armangué, T., Petit-Pedrol, M., Sabater, L., Martinez-Hernandez, E., Hara, M., Lancaster, E., Saiz, A., Dalmau, J., & Graus, F. (2016). Anti-LGI1-associated cognitive impairment: Presentation and long-term outcome. Neurology, 87(8), 759–765. https://doi.org/https://doi.org/10.1212/WNL.0000000000003009
- Benros, M. E., Nielsen, P. R., Nordentoft, M., Eaton, W. W., Dalton, S. O., & Mortensen, P. B. (2011). Autoimmune diseases and severe infections as risk factors for schizophrenia: A 30-year population-based register study. The American Journal of Psychiatry, 168(12), 1303–1310. https://doi.org/https://doi.org/10.1176/appi.ajp.2011.11030516
- Benros, M. E., Pedersen, M. G., Rasmussen, H., Eaton, W. W., Nordentoft, M., & Mortensen, P. B. (2014). A nationwide study on the risk of autoimmune diseases in individuals with a personal or a family history of schizophrenia and related psychosis. The American Journal of Psychiatry, 171(2), 218–226. https://doi.org/https://doi.org/10.1176/appi.ajp.2013.13010086
- Breggin, P. R. (1993). Parallels between neuroleptic effects and lethargic encephalitis: The production of dyskinesias and cognitive disorders. Brain and Cognition, 23(1), 8–27. https://doi.org/https://doi.org/10.1006/brcg.1993.1041
- Dalmau, J., & Graus, F. (2018). Antibody-mediated encephalitis. The New England Journal of Medicine, 378(9), 840–851. https://doi.org/https://doi.org/10.1056/NEJMra1708712
- Eaton, W. W., Byrne, M., Ewald, H., Mors, O., Chen, C., Agerbo, E., & Mortensen, P. B. (2006). Association of schizophrenia and autoimmune diseases: Linkage of Danish national registers. The American Journal of Psychiatry, 163(3), 521–528. https://doi.org/https://doi.org/10.1176/appi.ajp.163.3.521
- Eaton, W. W., Pedersen, M. G., Nielsen, P. R., & Mortensen, P. B. (2010). Autoimmune diseases, bipolar disorder, and non-affective psychosis. Bipolar Disorders, 12(6), 638–646. https://doi.org/https://doi.org/10.1111/j.1399-5618.2010.00853.x
- Evans, J. J., Wilson, B. A., Schuri, U., Andrade, J., Baddeley, A., Bruna, O., Canavan, T., Del Sala, S., Green, R., Laaksonen, R., Lorenzi, L., & Taussik, I. (2000). A comparison of errorless learning methods for teaching individuals with acquired memory deficits. Neuropsychological Rehabilitation, 10(1), 67–101. https://doi.org/https://doi.org/10.1080/096020100389309
- Finke, C., Kopp, U. A., Pajkert, A., Behrens, J. R., Leypoldt, F., Wuerfel, J. T., Ploner, C. J., Prüss, H., & Paul, F. (2016). Structural hippocampal damage following anti-N-methyl-D-aspartate receptor encephalitis. Biological Psychiatry, 79(9), 727–734. https://doi.org/https://doi.org/10.1016/j.biopsych.2015.02.024
- Frisch, C., Malter, M. P., Elger, C. E., & Helmstaedter, C. (2013). Neuropsychological course of voltage-gated potassium channel and glutamic acid decarboxylase antibody related limbic encephalitis. European Journal of Neurology, 20(9), 1297–1304. https://doi.org/https://doi.org/10.1111/ene.12186
- Gabilondo, I., Saiz, A., Galán, L., González, V., Jadraque, R., Sabater, L., Sans, A., Sempere, A., Vela, A., Villalobos, F., Viñals, M., Villoslada, P., & Graus, F. (2011). Analysis of relapses in anti-NMDAR encephalitis. Neurology, 77(10), 996–999. https://doi.org/https://doi.org/10.1212/WNL.0b013e31822cfc6b
- Irani, S. R., Bera, K., Waters, P., Zuliani, L., Maxwell, S., Zandi, M. S., Friese, M. A., Galea, I., Kullmann, D. M., Beeson, D., Lang, B., Bien, C. G., & Vincent, A. (2010). N-methyl-D-aspartate antibody encephalitis: Temporal progression of clinical and paraclinicalobservations in a predominantly non-paraneoplastic disorder of both sexes. Brain, 133(6), 1655–1667. https://doi.org/https://doi.org/10.1093/brain/awq113
- Kelleher, E., McNamara, P., Fitzmaurice, B., Walsh, R., Langan, Y., Whitty, P., Gill, M., Vincent, A., Doherty, C. P., & Corvin, A. (2015, May 28–29). Clinical implications of screening for NMDAR antibodies in first episode psychosis [Conference session]. Irish Neurological Society Conference. https://studylib.net/doc/6804359/ina-meeting-2015-scientific-programme
- Lee, W.-J., Lee, S.-T., Byun, J.-I., Sunwoo, J.-S., Kim, T.-J., Lim, J.-A., Moon, J., Lee, H. S., Shin, Y.-W., Lee, K.-J., Kim, S., Jung, K.-H., Jung, K.-Y., Chu, K., & Lee, S. K. (2016). Rituximab treatment for autoimmune limbic encephalitis in an institutional cohort. Neurology, 86(18), 1683–1691. https://doi.org/https://doi.org/10.1212/WNL.0000000000002635
- Lennox, B. R., Palmer-Cooper, E. C., Pollak, T., Hainsworth, J., Marks, J., Jacobson, L., Lang, B., Fox, H., Ferry, B., Scoriels, L., Crowley, H., Jones, P. B., Harrison, P. J., & Vincent, A. (2017). Prevalence and clinical characteristics of serum neuronal cell surface antibodies in first-episode psychosis: A case-control study. The Lancet. Psychiatry, 4(1), 42–48. https://doi.org/https://doi.org/10.1016/S2215-0366(16)30375-3
- Meixner, C., O’Donoghue, C. R., & Hart, V. (2017). Impact of the Brain Injury Family Intervention (BIFI) training on rehabilitation providers: A mixed methods study. NeuroRehabilitation, 40(4), 545–552. https://doi.org/https://doi.org/10.3233/NRE-171441
- Nosadini, M., Mohammad, S. S., Ramanathan, S., Brilot, F., & Dale, R. C. (2015). Immune therapy in autoimmune encephalitis: A systematic review. Expert Review of Neurotherapeutics, 15(12), 1391–1419. https://doi.org/https://doi.org/10.1586/14737175.2015.1115720
- Ojeda-Lopez, C., Espinola-Nadurille, M., & Gonzalez-Aguilar, A. (2015, March 26–27). Anti-NMDAR encephalitis: an unrecognized aetiology in catatonic patients? [Conference session]. The Lancet Neurology Autoimmune Disorders Conference, Spain.
- Ramanathan, S., Wong, C. H., & Fung, V. S. (2013). Long duration between presentation of probable anti-N-methyl-D-aspartate receptor encephalitis and either clinical relapse or positive serum autoantibodies. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia, 20(9), 1322–1323. https://doi.org/https://doi.org/10.1016/j.jocn.2012.10.023
- Samarasekera, S. R., Vincent, A., Welch, J. L., Jackson, M., Nichols, P., & Griffiths, T. D. (2007). Course and outcome of acute limbic encephalitis with negative voltage-gated potassium channel antibodies. Journal of Neurology, Neurosurgery, and Psychiatry, 78(4), 391–394. https://doi.org/https://doi.org/10.1136/jnnp.2006.093096
- Sarkis, R., Nehme, R., & Chemali, Z. N. (2014). Neuropsychiatric and seizure outcomes in nonparaneoplastic autoimmune limbic encephalitis. Epilepsy & Behavior: E&B, 39, 21–25. https://doi.org/https://doi.org/10.1016/j.yebeh.2014.07.018
- Scott, J. G., Gillis, D., Ryan, A. E., Hargovan, H., Gundarpi, N., McKeon, G., Hatherill, S., Newman, M. P., Parry, P., Prain, K., Patterson, S., Wong, R. C. W., Wilson, R. J., & Blum, S. (2018). The prevalence and treatment outcomes of antineuronal antibody-positive patients admitted with first episode of psychosis. BJPsych Open, 4(2), 69–74. https://doi.org/https://doi.org/10.1192/bjo.2018.
- Shin, Y. W., Lee, S. T., Park, K. I., Jung, K. H., Jung, K. Y., Lee, S. K., & Chu, K. (2018). Treatment strategies for autoimmune encephalitis. Therapeutic Advances in Neurological Disorders. https://doi.org/https://doi.org/10.1177/1756285617722347
- Steiner, J., Walter, M., Glanz, W., Sarnyai, Z., Bernstein, H.-G., Vielhaber, S., Kästner, A., Skalej, M., Jordan, W., Schiltz, K., Klingbeil, C., Wandinger, K.-P., Bogerts, B., & Stoecker, W. (2013). Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis. JAMA Psychiatry, 70(3), 271–278. https://doi.org/https://doi.org/10.1001/2013.jamapsychiatry.86
- Titulaer, M. J., McCracken, L., Gabilondo, I., Armangué, T., Glaser, C., Iizuka, T., Honig, L. S., Benseler, S. M., Kawachi, I., Martinez-Hernandez, E., Aguilar, E., Gresa-Arribas, N., Ryan-Florance, N., Torrents, A., Saiz, A., Rosenfeld, M. R., Balice-Gordon, R., Graus, F., & Dalmau, J. (2013). Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: An observational cohort study. The Lancet Neurology, 12(2), 157–165. https://doi.org/https://doi.org/10.1016/S1474-4422(12)70310-1
- Tüzün, E., & Dalmau, J. (2007). Limbic encephalitis and variants: Classification, diagnosis and treatment. The Neurologist, 13(5), 261–271. https://doi.org/https://doi.org/10.1097/NRL.0b013e31813e34a5
- van Sonderen, A., Thijs, R. D., Coenders, E. C., Jiskoot, L. C., Sanchez, E., de Bruijn, M. A. A. M., van Coevorden-Hameete, M. H., Wirtz, P. W., Schreurs, M. W. J., Sillevis Smitt, P. A. E., & Titulaer, M. J. (2016). Anti-LGI1 encephalitis: Clinical syndrome and long-term follow-up. Neurology, 87(14), 1449–1456. https://doi.org/https://doi.org/10.1212/WNL.0000000000003173
- Wang, L.-Y., Chen, S.-F., Chiang, J.-H., Hsu, C.-Y., & Shen, Y.-C. (2018). Autoimmune diseases are associated with an increased risk of schizophrenia: A nationwide population-based cohort study. Schizophrenia Research, 202, 297–302. https://doi.org/https://doi.org/10.1016/j.schres.2018.06.033
- Ylvisaker, M., Turkstra, L. S., & Coelho, C. (2005). Behavioral and social interventions for individuals with traumaticbrain injury: A summary of the research with clinical implications. Seminars in Speech and Language, 26(04), 256–267. https://doi.org/https://doi.org/10.1055/s-2005-922104